DOSSIER · 13F-HR · Q1 2026

Caligan Partners LP

Caligan's asset manager based in Stamford, CT $1.5B in tracked AUM across 28 positions as of Q1 2026.

C
Caligan·Stamford, CT·Asset Manager
CIK 0001727492 · last filed Mar 31, 2026
Total AUM
$1.5B
7.9%
vs prior
Holdings
28
positions
Whale Score
72
72
strong
Activity
no data
changes this Q
Top sector
Tech
9% weight
concentration
AI Analysis · Q1 2026 · Q1 2026
Comprehensive Analysis of Caligan Partners LP SEC 13F Filing
Portfolio Overview

Caligan Partners LP manages a highly concentrated, high-conviction portfolio totaling approximately $606.23 million as of the report date September 30, 2025. The fund experienced significant growth during the quarter, with total assets under management (AUM) increasing by 16.5%, rising from $520.17 million in the previous quarter. The portfolio consists of only 15 holdings, indicating a strategy that prioritize...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
LQDA
LIQUIDIA CORPORATION
$306M8.1M20.4%
02
RVMD
REVOLUTION MEDICINES INC
$183M1.9M12.2%
03
ABVX
ABIVAX SA
$163M1.5M10.8%
04
PCVX
VAXCYTE INC
$120M2.1M8.0%
05
XENE
XENON PHARMACEUTICALS INC
$81M1.4M5.4%
06
MLYS
MINERALYS THERAPEUTICS INC
$75M2.8M5.0%
07
EXEL
EXELIXIS INC
$67M1.6M4.4%
08
CGON
CG ONCOLOGY INC
$61M900K4.1%
09
TNGX
TANGO THERAPEUTICS INC
$50M2.4M3.4%
10
TYRA
TYRA BIOSCIENCES INC
$49M1.3M3.3%

Filing history

Filing history loading…